Archived Event
The Alliance Advancement Series
Moving Toward Better Quality and Uniformity in Brain Death Determination: Ethical and Legal Considerations
Presented on: Thursday, December 16, 2021
Familiarity of the legal and ethical considerations related to Brain Death Declaration is critical for healthcare professionals to ensure a continued collaborative approach to patient care and family support. This webinar will present a point-counterpoint discussion on key questions and issues currently impacting brain death determination. Specific areas of focus include a review of the current criteria for brain death determination, consent requirements for brain death testing or withdrawal of the ventilator, and religious objections and exemptions.
- Describe the current and future landscape of Brain Death Determination.
- Assess the significance and impact of inconsistent state laws on the declaration of death.
- Discuss ethical considerations surrounding Brain Death Declaration in Adult and Pediatric Patients.
David M. Greer
MD, MA, FCCM, FAHA, FNCS, FAAN, FANA
Chief
Department of Neurology, Boston Medical Center
Board, Moderator, National Donor Management Summit Planning Committee, National Pediatric Summit Planning Committee, Speaker
Matthew Kirschen
MD, PhD
Assistant Professor in Anesthesiology and Critical Care Medicine, Pediatrics, and Neurology, and the Associate Director of Pediatric Neurocritical Care
University of Pennsylvania Perelman School of Medicine, The Children's Hospital of Philadelphia
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.
Continuing Education Credits
Continuing Education credits are no longer available for this learning opportunity.
